Lionel Stéphan
Technology Transfer Advisor
Quebec Canada
Professional Status
Employed
Available
About Me
The best way to predict the future is to create it - Alan Kay.
I currently work as a Technology Transfer Advisor at SOVAR. More detailed descriptions of my current and previous positions can be found below.
Please feel free to contact me if you have collaboration suggestions or any questions related to my expertise!
Specialties: Technology Transfer, Business Development, Market Study, Start-up Management, Biotechnology.
I currently work as a Technology Transfer Advisor at SOVAR. More detailed descriptions of my current and previous positions can be found below.
Please feel free to contact me if you have collaboration suggestions or any questions related to my expertise!
Specialties: Technology Transfer, Business Development, Market Study, Start-up Management, Biotechnology.
Technology Transfer Advisor
Sovar
Since August 2010
- Sovar works in synergy with researchers in order to properly identify commercial applications for their discoveries, define the steps needed to demonstrate technical and commercial viability, determine the financial needs and help raise the required funding for the project. SOVAR works in close collaboration with researchers all along the project. At the end of the process, SOVAR manages the technology transfers to existing or spin-off companies.
VP Business development
Biovelia inc.
October 2008
to March 2012
- BioVelia is a privatly held start-up providing active delivery systems for the middle and premium nutraceutical and food supplement. The technologies developed from food polymers are adapted to the unmet needs of designers and marketers of nutraceutical products/food supplements. As VP Business development I helped Biovelia to raise funds (Programme d'appui à l'innovation (volet 1) — Soutien aux entreprises technologiques en démarrage) and private investment.
President, CEO
MI Revolution Inc.
August 2006
to October 2008
- MI Revolution was a business accelerator. We offered services to help seed biotech. projects. Biovelia inc. is the concrete result of our work.
PhD student at J.P Tremblay Laboratory
Centre hospitalier universitaire de Québec
January 2001
to January 2006
- I developed a tolerance protocol in the context of myoblasts transplantation for DMD (Duchenne Muscular Dystrophy) patients.
Master's Degree training course
INSERM
January 1999
to January 2001
- I worked on the development of antibodies targeting opioid receptors.